Futures fell after Trump said the U.S. will raise tariffs on more than $500 billion worth of Chinese imports, increasing trade tensions.Marketsread more
Clouding the G-7 gathering, which represents the world's major industrial economies, are the tit-for-tat tariffs between Washington and Beijing.Politicsread more
Hours after President Trump said Sunday he had "second thoughts" about escalating the trade war with China, the White House sought to explain his remark because it was...Politicsread more
President Donald Trump said that he would have a major trade deal with U.K. after it leaves the European Union.Politicsread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
Despite Kudlow's expectations, China said on Saturday that it strongly opposes Trump's decision to levy additional tariffs on $550 billion worth of Chinese goods, and warned...Politicsread more
President Donald Trump said Sunday he was not happy after North Korea launched short-range ballistic missiles over the weekend.Politicsread more
Bryn Mawr Trust CIO Jeffrey Mills lists where to put money to work as Wall Street copes with trade war and recession jitters.Futures Nowread more
The announcement for Target also comes on the heels of a strong quarterly earnings report, where it showed it drove more people to stores and got them to spend more money...Retailread more
The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
CVS Health Corp.: "Here's what I've been telling club members of ActionAlertsPlus.com, which follows along with my charitable trust: I think CVS is one of the absolute cheapest stocks, now that it's bought Aetna, in the country, and [CEO] Larry Merlo should come on air and tell us about it. "
Neogenomics Inc.: "Cancer genetics is a very, very big, great, speculative area. We saw that from Loxo Oncology when [Eli] Lilly bought that company. I am not going to say that you can't speculate on that. I am brazen. "
Vicor Corp.: "No. Power systems I regard as a commodity. I've looked at the company over and over again. I'm going to say don't buy."
T. Rowe Price Group: "A lot of people have turned a lot on all of these stocks that have to do with equities, picking equities. This yields 3 percent. It's a very well-run company. I'm not going to tell you to go away from it. I'm going to tell you to go toward it."
The Clorox Co.: "You are paying a high multiple for Clorox. One of my themes this week and last week was the high multiple you're paying for safety. I like Clorox. I regard it as the best of the consumer packaged goods. But always remember it is an expensive stock, and I'd prefer to get it at maybe a 3 percent yield instead of 2.6. But [CEO] Benno Dorer is doing terrific."